552 related articles for article (PubMed ID: 34671273)
1. Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?
Shoshan-Barmatz V; Anand U; Nahon-Crystal E; Di Carlo M; Shteinfer-Kuzmine A
Front Physiol; 2021; 12():730048. PubMed ID: 34671273
[TBL] [Abstract][Full Text] [Related]
2. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
[TBL] [Abstract][Full Text] [Related]
3. Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase.
Shoshan-Barmatz V; Zakar M; Rosenthal K; Abu-Hamad S
Biochim Biophys Acta; 2009 May; 1787(5):421-30. PubMed ID: 19094960
[TBL] [Abstract][Full Text] [Related]
4. Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction.
Ben-Hail D; Begas-Shvartz R; Shalev M; Shteinfer-Kuzmine A; Gruzman A; Reina S; De Pinto V; Shoshan-Barmatz V
J Biol Chem; 2016 Nov; 291(48):24986-25003. PubMed ID: 27738100
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial VDAC1: A Key Gatekeeper as Potential Therapeutic Target.
Camara AKS; Zhou Y; Wen PC; Tajkhorshid E; Kwok WM
Front Physiol; 2017; 8():460. PubMed ID: 28713289
[TBL] [Abstract][Full Text] [Related]
6. Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.
Shoshan-Barmatz V; Krelin Y; Shteinfer-Kuzmine A; Arif T
Front Oncol; 2017; 7():154. PubMed ID: 28824871
[TBL] [Abstract][Full Text] [Related]
7. VDAC1 functions in Ca
Shoshan-Barmatz V; Krelin Y; Shteinfer-Kuzmine A
Cell Calcium; 2018 Jan; 69():81-100. PubMed ID: 28712506
[TBL] [Abstract][Full Text] [Related]
8. The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy.
Smilansky A; Dangoor L; Nakdimon I; Ben-Hail D; Mizrachi D; Shoshan-Barmatz V
J Biol Chem; 2015 Dec; 290(52):30670-83. PubMed ID: 26542804
[TBL] [Abstract][Full Text] [Related]
9. VDAC1, mitochondrial dysfunction, and Alzheimer's disease.
Shoshan-Barmatz V; Nahon-Crystal E; Shteinfer-Kuzmine A; Gupta R
Pharmacol Res; 2018 May; 131():87-101. PubMed ID: 29551631
[TBL] [Abstract][Full Text] [Related]
10. Preserving Insulin Secretion in Diabetes by Inhibiting VDAC1 Overexpression and Surface Translocation in β Cells.
Zhang E; Mohammed Al-Amily I; Mohammed S; Luan C; Asplund O; Ahmed M; Ye Y; Ben-Hail D; Soni A; Vishnu N; Bompada P; De Marinis Y; Groop L; Shoshan-Barmatz V; Renström E; Wollheim CB; Salehi A
Cell Metab; 2019 Jan; 29(1):64-77.e6. PubMed ID: 30293774
[TBL] [Abstract][Full Text] [Related]
11. Metformin: Is it a drug for all reasons and diseases?
Triggle CR; Mohammed I; Bshesh K; Marei I; Ye K; Ding H; MacDonald R; Hollenberg MD; Hill MA
Metabolism; 2022 Aug; 133():155223. PubMed ID: 35640743
[TBL] [Abstract][Full Text] [Related]
12. VDAC, a multi-functional mitochondrial protein regulating cell life and death.
Shoshan-Barmatz V; De Pinto V; Zweckstetter M; Raviv Z; Keinan N; Arbel N
Mol Aspects Med; 2010 Jun; 31(3):227-85. PubMed ID: 20346371
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial VDAC1: function in cell life and death and a target for cancer therapy.
Shoshan-Barmatz V; Golan M
Curr Med Chem; 2012; 19(5):714-35. PubMed ID: 22204343
[TBL] [Abstract][Full Text] [Related]
14. Knockout of VDAC1 in H9c2 Cells Promotes Oxidative Stress-Induced Cell Apoptosis through Decreased Mitochondrial Hexokinase II Binding and Enhanced Glycolytic Stress.
Yang M; Sun J; Stowe DF; Tajkhorshid E; Kwok WM; Camara AKS
Cell Physiol Biochem; 2020 Sep; 54(5):853-874. PubMed ID: 32901466
[TBL] [Abstract][Full Text] [Related]
15. VDAC1: from structure to cancer therapy.
Shoshan-Barmatz V; Mizrachi D
Front Oncol; 2012; 2():164. PubMed ID: 23233904
[TBL] [Abstract][Full Text] [Related]
16. The BH4 domain of anti-apoptotic Bcl-XL, but not that of the related Bcl-2, limits the voltage-dependent anion channel 1 (VDAC1)-mediated transfer of pro-apoptotic Ca2+ signals to mitochondria.
Monaco G; Decrock E; Arbel N; van Vliet AR; La Rovere RM; De Smedt H; Parys JB; Agostinis P; Leybaert L; Shoshan-Barmatz V; Bultynck G
J Biol Chem; 2015 Apr; 290(14):9150-61. PubMed ID: 25681439
[TBL] [Abstract][Full Text] [Related]
17. Voltage-dependent anion channel 1-based peptides interact with hexokinase to prevent its anti-apoptotic activity.
Arzoine L; Zilberberg N; Ben-Romano R; Shoshan-Barmatz V
J Biol Chem; 2009 Feb; 284(6):3946-55. PubMed ID: 19049977
[TBL] [Abstract][Full Text] [Related]
18. VDAC, a multi-functional mitochondrial protein as a pharmacological target.
Shoshan-Barmatz V; Ben-Hail D
Mitochondrion; 2012 Jan; 12(1):24-34. PubMed ID: 21530686
[TBL] [Abstract][Full Text] [Related]
19. Aspirin induces cell death by directly modulating mitochondrial voltage-dependent anion channel (VDAC).
Tewari D; Majumdar D; Vallabhaneni S; Bera AK
Sci Rep; 2017 Mar; 7():45184. PubMed ID: 28327594
[TBL] [Abstract][Full Text] [Related]
20. VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia.
Prezma T; Shteinfer A; Admoni L; Raviv Z; Sela I; Levi I; Shoshan-Barmatz V
Cell Death Dis; 2013 Sep; 4(9):e809. PubMed ID: 24052077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
